Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial flavoenzymes are a diverse group of proteins that utilize flavin adenine dinucleotide (FAD) or flavin mononucleotide (FMN) as essential cofactors to catalyze a wide range of redox reactions (Joosten & van Berkel, 2007, https://doi.org/10.1016/j.cbpa.2007.01.010). These enzymes play critical roles in bacterial metabolism, including the respiratory chain, fatty acid oxidation, and the biosynthesis of essential nutrients (Massey, 2000, https://doi.org/10.1042/bst0280283). In the context of pharmacology, they are significant because several clinical antibiotics, such as nitrofurantoin and metronidazole, act as prodrugs that are specifically activated by bacterial flavoenzymes, such as oxygen-insensitive nitroreductases, into toxic reactive species that damage bacterial DNA and proteins (Williams et al., 2015, https://doi.org/10.1099/mic.0.000011). Furthermore, because certain bacterial flavoenzymes have unique structural features or metabolic roles not found in humans, they are being actively explored as targets for novel narrow-spectrum antimicrobial agents (Macheroux et al., 2011, https://doi.org/10.1111/j.1742-4658.2011.08060.x). However, the high degree of conservation in some flavin-binding sites poses a challenge for achieving selectivity over human mitochondrial flavoenzymes (Walsh & Wencewicz, 2016, Antibiotics: Challenges, Mechanisms, Opportunities).
Reductive bioactivation of prodrugs into reactive radicals; Competitive inhibition of flavin cofactor binding; Covalent modification of the flavin prosthetic group.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial flavoenzyme.